Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
September 04 2009 - 5:43PM
PR Newswire (US)
SEATTLE, Sept. 4 /PRNewswire-FirstCall/ -- Dendreon Corporation
(NASDAQ: DNDN) today announced that management will present at the
following four upcoming investor conferences. Rodman & Renshaw
11th Annual Health Care Conference Wednesday, September 9, 2009
4:05 p.m. ET Morgan Stanley 2009 Global Health Care Unplugged
Conference Tuesday, September 15, 2009 8:35 a.m. ET BioCentury 16th
Annual NewsMakers in the Biotech Industry Conference Wednesday,
September 16, 2009 1:30 p.m. ET UBS 2009 Global Life Sciences
Conference Wednesday, September 23, 2009 1:00 p.m. ET The
presentations at Rodman & Renshaw, BioCentury NewsMakers and
UBS will be audio webcast live and available for replay from
Dendreon's website, http://www.dendreon.com/. Dendreon Corporation
is a biotechnology company whose mission is to target cancer and
transform lives through the discovery, development and
commercialization of novel therapeutics. The Company applies its
expertise in antigen identification, engineering and cell
processing to produce active cellular immunotherapy product
candidates designed to stimulate an immune response. Dendreon is
also developing an orally-available small molecule that targets
TRPM8 that could be applicable to multiple types of cancer as well
as benign prostatic hyperplasia. The Company has its headquarters
in Seattle, Washington and is traded on the Nasdaq Global Market
under the symbol DNDN. For more information about the Company and
its programs, visit http://www.dendreon.com/. DATASOURCE: Dendreon
Corporation CONTACT: Jennifer Williams, Investor Relations of
Dendreon Corporation, +1-206-829-1500 Web Site:
http://www.dendreon.com/
Copyright